Stockreport

enVVeno Medical Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]

enVVeno Medical Corporation  (NVNO) 
PDF Topline efficacy data for VenoValve® U.S. pivotal trial to be presented at the VENOUS2024 American Venous Forum Annual Meeting on March 6, 2024 Continued progress tow [Read more]